Floatz logo

Vindesine

Burkitt Lymphoma

PETHEMA FoundationSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
61/ 100
Competitive Position
95/ 100

Competitive context

72 Active assets in the Burkitt Lymphoma cohort.

Asset / SponsorPhaseRating
Nivestim
Fred Hutchinson Cancer Center
Phase 4BBB
Vincristine sulfate
AIDS Malignancy Consortium
Phase 2BBB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 4BBB
Cyclosporin A
Fred Hutchinson Cancer Center
Phase 2BBB
Romidepsin
M.D. Anderson Cancer Center
Phase 2BBB

View all 50 →

Same molecule, other indications

Vindesine is also rated in:

B-cell non-Hodgkin lymphomaActive
BBB
Indicative · Phase 4
78 / 100
View asset →
adult acute lymphoblastic leukemiaActive
BBB
Indicative · Phase 4
78 / 100
View asset →
lymphoblastic lymphomaActive
BBB
Indicative · Phase 4
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →